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ABSTRACT
Introduction: Cholecystokinin (CCK) and peptide YY (PYY) are satiety-stimulating 
hormones that are released during eating. As such, their levels may be used useful 
in obesity intervention. The aims of this study were to determine the optimal cut-
off values, sensitivity and specificity of plasma CCK and PYY in adult men, in 
order to determine hormonal dysfunction in obesity.  Methods: We investigated 
16 obese [body mass index (BMI) ≥25.1)] and 16 normal weight (BMI 18.5–22.9) 
men. They ate isocaloric fast-food for breakfast. Blood for the determination of the 
hormones was collected at 0 (before), 30, 60, and 120 minutes after consumption. 
The data that was obtained were analysed using an independent t-test or the Mann–
Whitney U-test. The receiver operating characteristic (ROC) curve was drawn and 
the trapezoidal rule analysis was performed to determine the area under the curve, 
to determine the optimal cut-off values, sensitivity and specificity.  Results: In 
obese subjects, CCK was lower compared with normal weight subjects at any time 
(p<0.05). There were no major differences in PYY among subject groups. ROC curve 
analysis demonstrated that the plasma CCK had an optimal cut-off of 6,310 pg/
ml at 120 minutes after eating, with 0.97 area under curve (AUC), sensitivity was 
94%, and specificity was 94%. The cut-off for optimal PYY was an average of 294.5 
pg/ml at 120 minutes after eating (AUC 0.74; sensitivity 75%; specificity 75%).  
Conclusion: Our findings suggest that the plasma CCK level is a better potential 
predictor of obesity and constantly decreased over time compared to PYY.
Keywords: Cholecystokinin, peptide yy, obese, receiver operating characteristic
INTRODUCTION
The high prevalence of obesity has 
emerged as a health concern since it is a 
risk factor of chronic disease (Heymsfield 
& Wadden, 2017). In Indonesia, 19.7% 
of the men and 32.9% of the women 
were obese in 2013 (NIHRD, 2013). The 
combined prevalence of men and women 
increased to 21.8% in 2018 (NIHRD, 
2018). Between 2013 and 2018, overall 
central obesity increased by about 5.0% 
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(26.6% to 31.0%). Excessive energy 
intake, as the cause of obesity, involves 
the brain-gut axis in the central nervous 
system. Hormones such as peptide YY 
(PYY) and cholecystokinin (CCK) play a 
role in decreasing appetite (Posovszky & 
Wabitsch, 2015).
PYY and CCK have been known as 
satiety hormones contributing to the 
delay and inhibition of gastric emptying 
(Adamska et al., 2014). In humans, low 
levels of PYY have been associated with 
obese patients (Batterham et al., 2003). 
An animal study found low PYY levels 
in obese rats and high PYY in lean rats, 
suggesting that PYY deficiency plays 
a role in the pathogenesis of obesity 
(Moghadam, Moran & Dailey, 2017). 
A human study also showed that CCK 
concentrations in metabolic syndrome 
that followed morbid obesity were 
significantly lower than those in lean 
control subjects (Zwirska-Korczala et al., 
2007). It can thus be inferred that the 
alteration in PYY and CCK hormones are 
intimately associated with obesity.
The gut hormones have been 
investigated as a potential therapeutic 
target for obesity. Recently, acylated 
ghrelin (AG), an energy homeostasis 
regulator hormone, has been one of 
the targets for obesity therapy using 
ghrelin O-acyltransferase (GOAT) 
inhibitor (Khatib et al., 2015). Andarini, 
Kangsaputra & Handayani (2017) 
investigated the AG levels and optimal 
cut-off values in normal and obese 
patients using receiver-operating 
characteristic (ROC) curve analysis. The 
investigation revealed that there was 
a significant difference in AG levels, 
and the optimal cut-offs were 2,332 
pg/ml before eating (sensitivity 88%; 
specificity 100%) and 2,710 pg/ml at 
30 minutes after eating (sensitivity 88%; 
specificity 100%) (Andarini et al., 2017). 
Determination of gut hormone cut-offs 
would assist in establishing rational 
therapeutic principles in obesity therapy 
management. Some researchers have 
found that appetite control hormones, 
CCK and PYY, can also be potential 
therapeutic targets in the management 
of obesity (Perry & Wang, 2012; 
Olszanecka-Glinianowicz et al., 2013; 
Prinz & Stengel, 2017). CCK and PYY 
deficiency in obese subjects, treatment 
with CCK and PYY has been attempted. 
However, an animal study demonstrated 
that chronic CCK administration induced 
pancreatitis in rats, and high dose PYY 
infusion produces vomiting and nausea 
(Degen et al., 2005; Jia, Yamamoto & 
Otsuki, 2015). 
The current literature provides 
limited information on CCK and PPY 
cut-off levels. This aim of this study 
was to investigate CCK and PYY levels 
between obese men and control, and to 
assess the optimal cut-off, sensitivity 




This study was conducted in Malang, 
Indonesia. It aimed to obtain and 
compare the optimal cut-off values, 
sensitivity, and specificity of CCK and 
PYY plasma levels using ROC analysis to 
evaluate pre- and post-prandial plasma 
CCK and PYY. Participants were given 
isocaloric food (51% carbohydrate, 33% 
fat, and 13% protein) and water for 
breakfast after overnight fasting. Fasting 
blood samples were collected before 
breakfast (0 minutes), and 30, 60, and 
120 minutes after breakfast. The study 
was approved by the Ethical Committee 
of Medical Faculty of Universitas 
Brawijaya (No. 389/EC/KEPK/2015).
Test meals
One serving of commercial fast-food 
containing similar amounts of energy 
(546–593 kcal) was provided to the 32 
participants at breakfast time. The 
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meals were obtained from a popular fast-
food franchise restaurant in Malang, 
Indonesia. This study used commercial 
fast-food since the community expressed 
a preference for it. 
Previous studies have reported that 
the consumption of fast-foods correlated 
with obesity (Janet et al., 2010; 
Andreyeva, Kelly & Harris, 2011). The 
total energy and macronutrient content 
are presented in our previous study 
(Handayani et al., 2017). The amount 
of energy was analysed using a bomb 
calorimetric, protein was assayed by the 
Kjeldahl method and fibre by enzymatic 
analysis.
Participants
Sixteen men with normal weight and 
16 obese men were recruited. Males 
were chosen as the participants due to 
their stable energy intake, since females 
have a fluctuating energy intake within 
their menstrual cycle. The physiological 
responses to hunger and satiety also differ 
between male and female (Bédard et al., 
2015). Pre-screening was performed to 
determine healthy participants without 
a previous history of diabetes mellitus, 
hypercholesterolemia, or hypertension. 
Blood pressure, blood glucose and 
plasma cholesterol levels were 
measured using sphygmomanometer, 
blood glucose test kit and the multi-
monitoring system Autocheck FDA-
CE197, respectively. Plasma leptin was 
measured using competitive enzyme-
linked immunosorbent assay (ELISA) 
(KIT: CAN-L-4260, DB Canada). The 
percentage (%) body weight and % waist 
fat were measured using bioelectrical 
impedance analysis (BIA)-Omron type 
HBF 375.  All participants provided 
informed consent for the study.
Blood biochemistry examination
Fasting blood samples were collected 
for CCK and PYY from participants 
before eating, and at 30, 60 and 120 
minutes after. Plasma was separated 
from blood samples by centrifugation 
at 3,000 revolutions per minute (rpm) 
for 10 minutes at 25°C using PLC-05 
tabletop centrifuge (Gammy Industrial 
Corporation, Taiwan, in association with 
Cannic, Inc., USA) and then was stored 
at -80˚C until analysis.
Plasma CCK (pg/ml) was measured 
using competitive ELISA (E-EL-H0723; 
Elabscience, Biotechnology, Beijing). 
Plasma PYY (pg/ml) was measured 
using sandwich ELISA (E-EL-H1237; 
Elabscience, Biotechnology, Beijing). The 
plasma samples were added onto a pre-
coated microtiter plate and combined 
with biotinylated detection antibody. 
After incubation at 37°C, horseradish 
peroxidase (HRP) conjugate was added 
and incubated. The substrate reagent 
was added for the colour reaction. The 
optical density (OD) was measured at a 
wavelength of 450.0±2.0nm. CCK and 
PYY hormone levels were obtained from 
the OD of the samples and the standard 
curve.
Statistical analysis
The data are presented as a 
mean±standard deviation (SD). The 
baseline comparison between obese and 
normal weight men was examined using 
the independent t-test. For CCK and PYY 
levels, differences between obese and 
normal weight were examined by using 
the independent t-test for normally 
distributed data and Mann-Whitney U 
test for abnormally distributed data. 
The area under the curve (AUC) of CCK 
and PYY was performed by calculating 
the graphic trapezoid. The AUC scores 
were interpreted as excellent if ≥0.90, 
good if 0.80–0.89, fair if 0.70–0.79, 
and poor if <0.70 (Kendzor, Caughy & 
Owen, 2012). The optimal cut-off values 
of CCK and PYY were determined using 
the ROC curve. Statistical analyses were 
performed using Statistical Package 
for the Social Sciences (SPSS) version 
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16 (IBM, Chicago, IL, USA).  Statistical 
analyses were considered as significant 
at p<0.05.
RESULTS
Characteristics of the research 
participants
In total, 32 adult men (16 normal 
weight and 16 obese) were recruited for 
the study. The mean age was 21.4±1.9 
years for the obese men and 20.6±1.1 
years for the normal weight men. Obese 
men were heavier and had significantly 
higher (p<0.01) BMI (≥25.1), body fat 
percentage, and waist fat percentage 
than did normal weight men whose 
BMI was 18.5–22.9 (Table 1). The obese 
men had higher levels of systolic blood 
pressure, diastolic blood pressure (DBP), 
total cholesterol, and leptin (Table 1) 
(Andarini et al., 2017).
CCK and PYY
The mean±SD of CCK and PYY levels 
in time points are shown in Table 2. In 
CCK, there was significant difference in 
the mean values of the obese and normal 
weight groups (p<0.002). Moreover, there 
was a decrease in CCK concentration 
in the obese group at the different time 
points (before eating, 30 minutes after 
eating, 60 minutes after eating, and 120 
minutes after eating) but this did not 
show in the normal weight group. There 









Age (years) 21.4±1.9 20.6±1.1 0.18
Weight (kg) 97.0±1.9 60.9±5.7 <0.01
Height (cm) 170.0±5.5 169.0±6.3 0.89
BMI (kg/m2) 33.6±4.8 21.2±1.1 <0.01
Body fat (%) 30.2±3.8 17.0±5.1 <0.01
Waist fat (%) 16.7±4.1 4.7±1.0 <0.01
Waist circumference (cm) 105.0±12.0 75.4±4.2 <0.01
Systolic blood pressure (mm/Hg) 124.0±9.6 117.0±6.8 0.04
Diastolic blood pressure (mm/Hg) 80.6±4.4 75.0±5.2 <0.01
Random blood sugar (g/dL) 122.0±21.1 103.0±12.2 0.16
Total cholesterol (g/dL) 135.0±27.7 94.8±49.8 <0.01
Leptin (pg/mL) 61.9±21.8 21.6±9.1 <0.01







CCK 0 min (pg/ml) 7045.6±738.1 8234.4±950.8 <0.002
CCK 30 min (pg/ml) 6371.8±738.1 8033.1±1334.3 <0.001
CCK 60 min (pg/ml) 6195.0±746.7 8395.6±1134.1 <0.001
CCK 120 (pg/ml) 5275.0±789.6 8799.4±1595.9 <0.001
PYY 0 min (pg/ml) 251.9±190.8 155.9±92.3 0.036
PYY 30 min (pg/ml) 279.0±190.8 346.9±113.9 0.121
PYY 60 min (pg/ml) 478.8±263.0 363.1±137.2 0.129
PYY 120 min (pg/ml) 248.3±187.6 353.1±119.1 0.069
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were no significant differences in PYY 
levels between the obese and normal 
weight groups.
CCK and PYY as an alternative 
biomarker test for obesity
Table 3, Figure 1(a), and Figure 1(b) 
shows optimal cut-off points and area 
under ROC curve for CCK and PYY on 
each time point. The ROC curve of CCK 
and PYY showed the highest sensitivity 
and specificity at 120 minutes after 
eating. ROC analysis of CCK showed a 
cut-off value of 6,310 pg/ml, with area 
under curve (AUC) of 0.97, sensitivity 
was 94% and specificity was 94%. The 
highest PYY levels showed highest 
sensitivity and specificity with a cut-
off value of 294.5 pg/ml (AUC, 0.74; 
sensitivity, 75%; specificity, 75%).
DISCUSSION
In recent years, the alteration of gut 
hormones that are related to obesity such 
as CCK and PYY has been documented. 
Those hormones play an important 
role in mediating satiation. The present 
study revealed that when sensitivity and 
specificity were 94% each, the optimal 
cut-off value of CCK was 6,310 pg/ml 
at 120 minutes after eating. At the same 
time, the optimal cut-off of PYY was at 
a lower sensitivity and specificity value 
Table 3. Cut-off, sensitivity, and specificity of CCK and PYY content before and after eating 










0 7665 0.82 75% 75% 191.5 0.27 38% 38%
30 7040 0.82 75% 75% 266.5 0.31 69% 69%
60 7015 0.96 88% 88% 369.0 0.37 44% 44%
120 6310 0.97 94% 94% 294.5 0.74 75% 75%
Figure 1. Receiver characteristics curve (ROC) of CCK (a) and PYY (b) at 120 minutes after 
eating 
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(75% and 75%, respectively) than CCK. 
There was a statistically significant 
difference between the CCK levels in 
obese and normal weight men at each 
of the time points of 0, 30, 60, and 120 
minutes, suggesting that obese people 
have lower CCK levels. However, there 
were no significant differences in PYY. 
The increasing CCK concentration 
indicates a lower gastric emptying 
rate through an appetite suppression 
mechanism and food intake reduction. 
Gastric motility will be suppressed by 
CCK release, resulting in slower gastric 
emptying which leads to prolonged 
gastric distension and satiety (Ma et al., 
2009; Li, Ma & Wang, 2011; Robert et 
al., 2015). Plasma CCK increased within 
15 minutes after meal initiation, went 
higher in 30 minutes and remained 
elevated over the 120 minutes initiation, 
and then decreased gradually. Our 
study confirmed that the decreased CCK 
concentration at time points contributes 
to a decrease of satiety and an increase 
of hunger in obese subjects (Ma et al., 
2009; Adamska et al., 2014; Robert et 
al., 2015).
Obesity has been significantly 
associated with rapid gastric emptying 
rates (Acosta et al., 2015). In this study, 
CCK levels were reported to be lower 
in obese than in normal-weight men. 
Our observations were consistent with 
those of Lean & Malkova (2016) who 
reported decreased CCK in obese and 
overweight compared to lean subjects 
after dietary intervention. Even though 
Brennan et al. (2012) demonstrated no 
major differences in CCK responses 
to macronutrients between lean and 
obese subjects, high protein content 
stimulated CCK production in their 
obese respondents compared to high fat. 
Another investigation found a delayed 
CCK response to oleic acid infusion in 
obese subjects compared to control 
groups (Stewart et al., 2011). These 
observations suggest that CCK in obese 
subjects is sensitive to protein and fat 
intake. Our finding confirms that the 
high-fat content in fast foods contributed 
to lower CCK in obese subjects compared 
to lean subjects. Also, some investigations 
found a synergistic interaction between 
CCK and leptin that resulted in short-
term satiety. Heldsinger et al. (2011) 
established that the Phosphoinositide 
3-kinase (PI3K) and Signal transducer 
and activator of transcription 3 (STAT3) 
signaling pathway can be mediated for 
CCK and leptin to activate vagal neurons 
which may contribute to food intake. The 
significant difference in leptin between 
obese and lean subjects may affect CCK 
in controlling satiation. Plasma leptin 
level in this study as reported in Table 1 
is higher in the obesity group compared 
to the normal weight group.  
The amount of CCK gradually 
decreased over time but increased in 
sensitivity and specificity with a peak 
at 120 min following the consumption 
of food. The mechanism underlying the 
increases of sensitivity and specificity 
over time remains unclear. However, 
the previous finding which revealed the 
inverse relationship between hunger 
and plasma CCK but not PYY explains 
that CCK is more sensitive in controlling 
satiety (Brennan et al., 2012). The result 
was consistent with the present study 
that PYY does not have good specificity 
and sensitivity as CCK, and the ROC 
curve appears to fluctuate. The better 
specificity and specificity over time 
in CCK also showed that time could 
determine the amount CCK released into 
circulation. 
PYY acts in the reduction of gastric 
emptying and the delay in intestinal 
transit, which is called ‘ileal brake’. PYY 
also has biological functions including 
reducing food intake, decreasing gastric 
emptying, and slowing gastrointestinal 
motility. The lack of endogenous PYY 
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secretion may lead to obesity development 
(Li et al., 2011; Adamska et al., 2014; 
Troke, Tan & Bloom, 2014). Some studies 
reported that obese subjects have lower 
fasting and postprandial plasma PYY 
than normal weight subjects. It has 
been reported that protein or fat has the 
strongest stimulant of PYY secretion and 
thus contribute to its increase in blood 
concentrations (Mittelman et al., 2010; 
Li et al., 2011; Lean & Malkova, 2016). 
The obese subjects had significantly 
higher hunger and lower satiety than 
the normal weight subjects. However, 
the postprandial PYY profiles were 
not translated into the feeling of less 
hungry or more fullness that led to a 
reduction in food intake (Lomenick, 
Clasey & Anderson, 2008; Lomenick et 
al., 2009; van der Klaauw et al., 2013). 
The PYY response was reported slightly 
higher immediately after exercising 
both in obese men and women. Lifestyle 
and environment factors do not have 
a significant impact on plasma PYY in 
men, but some factors such as smoking, 
medication use, and a post-menopause 
condition in women lead to an increase 
of circulating PYY concentration (Cahill 
et al., 2014; Lean & Malkova, 2016). 
Our data were also consistent with the 
latest study in older and middle-aged 
men by Madsen et al. (2019) who found 
that there was no difference in plasma 
concentration of PYY in response to lipid 
load. The 30-minute interval of test meal 
had been chosen based on previous 
studies which showed a significant 
difference in gut hormones (le Roux et 
al., 2006).
This study had several limitations. 
The first limitation was the small 
number of participants in each group. 
Secondly, even though the study used 
fast food meals with similar energy 
density, the serving size among the 
foods was different.  A previous study 
revealed that food form and portion size 
affect postprandial hormonal response 
in normal weight and obese subjects 
(Leidy et al., 2010). It is suggested that 
in future studies, the confounding factor 
of the test meal could be minimised by 
choosing the same food with similar 
serving size and macronutrient content. 
In this way, the focus would be more on 
analysing the sensitivity and specificity 
of the hormonal response. 
This study showed that CCK is 
more sensitive and specific than PPY 
in the study of gut hormones in obese 
subjects. This finding may enhance 
the development of appropriate gut 
hormonal testing and intervention to 
help to combat obesity.
CONCLUSION
At present, CCK is rarely considered 
as a gut hormone target in obesity 
management. However, we have 
established that CCK is better than 
PYY in predicting obesity from the 
significantly different amounts of 
CCK in obese and lean subjects at all 
time points.  Furthermore, we have 
demonstrated that CCK has better 
sensitivity and specificity over time, 
unlike PYY, which had a fluctuating 
ROC curve. Our findings suggest that 
CCK has potential in obesity treatment. 
Future studies are required to clarify the 
nutrients and hormones contributing to 
CKK release and the side effect(s) of CCK 
administration. 
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